Kyntra Bio KYNB
NASDAQ KYNB
$7.52 +0.20 (+2.73%)
At close: Aug 21, 2026 · 4:00 PM EDT

Kyntra Bio (KYNB) Amortizatization of Intangibles (2014 - 2026)

Kyntra Bio (KYNB) posted Amortizatization of Intangibles of $183000.0 for Q1 2026, up 150.68% sequentially from $73000.0 in Q4 2025, and up 18200.0% YoY from N/an in Q1 2025.

Kyntra Bio (KYNB) Amortizatization of Intangibles (2014 - 2026) Analysis & Trends

Kyntra Bio has reported Amortizatization of Intangibles for 13 years, with the latest figure at $183000.0 in Q1 2026.

  • Quarterly Amortizatization of Intangibles rose 18200.0% year-over-year to $183000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $254000.0 (up 775.86% YoY) and the FY2025 annual result came in at $72000.0, up 89.47% from the prior year.
  • Amortizatization of Intangibles climbed to $183000.0 in Q1 2026 per KYNB's latest filing, from $73000.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $2.4 million in Q4 2022 and troughed at -$1.7 million in Q3 2024.
  • A 5-year average of $76000.0 and a median of $10000.0 in 2023 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2022 and 2026: Amortizatization of Intangibles slumped 608.4% in 2022, then soared 18200.0% in 2026.
  • Over 5 years, Amortizatization of Intangibles stood at $2.4 million in 2022, then sank by 99.59% to $10000.0 in 2023, then changed by 0.0% to $10000.0 in 2024, then soared by 630.0% to $73000.0 in 2025, then jumped by 150.68% to $183000.0 in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $183000.0, $73000.0, and -$19000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Kyntra Bio 30.42 Mn 30.42 Mn 1.47 Mn 98,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 98,000.00
Jun 30, 2026 98,000.00
Mar 31, 2026 183,000.00
Mar 31, 2026 183,000.00
Dec 31, 2025 73,000.00
Dec 31, 2025 73,000.00
Sep 30, 2025 -19,000.00
Sep 30, 2025 -19,000.00
Jun 30, 2025 17,000.00
Jun 30, 2025 17,000.00
Mar 31, 2025 1,000.00
Mar 31, 2025 1,000.00
Dec 31, 2024 10,000.00
Dec 31, 2024 10,000.00
Sep 30, 2024 -1.65 Mn
Sep 30, 2024 -1.65 Mn
Jun 30, 2024 1.67 Mn
Jun 30, 2024 1.67 Mn
Mar 31, 2024 10,000.00
Mar 31, 2024 10,000.00